Our Mission

Advocate – Educate – Communicate

We strive to organize Bangladeshi-American Pharmacists in a strong and professional platform so they can be more successful in their career and have a fulfilling experience in this country. We work to get the members involved in the socio-political process that determines their future. We hope to motivate everyone to contribute their time and talent to the betterment of the pharmacy profession here at home and in Bangladesh.

Specifically, the purpose of the organization is to foster cooperation and collaboration among Bangladeshi pharmacists residing in North America; to build and maintain relations with other pharmacists’ associations in North America, to support the profession of pharmacy in Bangladesh and in North America; to support and encourage the development of Pharmaceutical Science in Bangladesh; to develop and conduct programs for maintaining and improving the professional standards; to promote welfare of members’ families in case of need; to protect the professional interests of members of the Association.

Our Sponsors

Silver Sponsor

Bronze Sponsor

Pharmaceutical News

  • AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030
    on May 21, 2024 at 8:00 am

    Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching an expected 20 new medicines before the end of the decade. To drive sustained growth beyond 2030, the Company will continue investing in transformative new technologies and platforms that will shape the future of medicine.

  • Clinicians report success with first test of drug in a patient with life-threatening blood clotting disorder
    on May 20, 2024 at 8:00 am

    A team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting throughout the small blood vessels. The group describes the first clinical use of the drug for iTTP in the New England Journal of Medicine.

  • A boost for HIV vaccine research
    on May 17, 2024 at 8:00 am

    HIV has proven a hard target for vaccine design. The most promising approach, germline-targeting (GT), proposes a series of immunizations: a first shot to activate inexperienced B cells - antibody-producing white blood cells - followed by a sequence of immunogens that are more and more like the HIV Envelope (Env) protein. The ultimate goal of GT immunization is to coach B cells into producing broadly neutralizing antibodies (bnAbs) capable of binding to conserved sites on HIV Env, which seldom change despite HIV's penchant for rapid diversification.

  • 'Trojan horse' weight loss drug more effective than available therapies
    on May 16, 2024 at 8:00 am

    "I consider the drugs available on the marked today as the first generation of weight-loss drugs. Now we have developed a new type of weight-loss drug that affects the plasticity of the brain and appears to be highly effective." So says Associate Professor and Group Leader Christoffer Clemmensen, from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, who is senior author of the new study, which has been published in the prestigious scientific journal Nature.

  • New study shows continued high effectiveness of HPV vaccination in England
    on May 15, 2024 at 8:00 am

    The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today. Although women living in the most deprived areas are still at higher risk of cervical disease than those in less deprived areas, the results show that well planned and executed public health interventions can both improve health and reduce health inequalities.